CDIO Cardio Diagnostics Holdings: Earnings growth forecast for next year
Cardio Diagnostics is implementing precision EpiCheck AI algorithms for the autonomous analysis of DNA markers. A strategic alliance with telemedicine services and cardiologists is accelerating the early diagnosis of pathologies. The estimated EPS growth for next year on this GURU.Markets platform chart confirms the trend, where the 0.00 metric reflects current dynamics. The company is also expanding profits through epigenetic tests for myocardial infarction prevention.
Analytical breakdowns for Cardio Diagnostics Holdings (CDIO)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- company liabilities and liquidity data:
Total Debt to Capital Cardio Diagnostics|CDIO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cardio Diagnostics Holdings Inc.|CDIO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Cardio Diagnostics|CDIO - Long-Term Debt|Company Current Liabilities Cardio Diagnostics|Quick Ratio cardiodiagnosticsinc.com
- earnings and valuation multiples information:
CDIO - Company Profit|Projected Future Earnings Cardio Diagnostics|CDIO - Business Payback Period|Forward P/E Multiple Cardio Diagnostics Holdings Inc.|CDIO - PEG Multiple|EV/EBITDA Multiple Cardio Diagnostics|CDIO - Operating profit before depreciation charges|Earnings per share for the last twelve months Cardio Diagnostics|CDIO - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com|CDIO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Cardio Diagnostics
Initial company analysis:CDIO, Cardio Diagnostics
To identify the fundamental drivers of stability for Cardio Diagnostics (CDIO), analyzing consensus earnings per share (EPS) forecasts is key, as the projected earnings change for the coming year reflects aggregated expert expectations for future profitability. The volatility of this chart indicates risks that, for Cardio Diagnostics (CDIO), are amplified by limited insurance coverage and low pricing power when introducing innovative tests to the market.
Competitors of Cardio Diagnostics
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ILMN|Expected earnings per share growth for next year exactsciences.com EXAS|Earnings growth forecast for next year RVTY (Revvity)|Earnings growth forecast for next year Bio-Rad Laboratories, Inc. BIO|NNNN - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SHC (Nordion)|QDEL: Earnings growth forecast for next year|Projected earnings per share growth rate for next year OPK|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|Maravai LifeSciences Holdings (MRVI) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Fulgent Corp (FLGT)|LAB - Expected net earnings per share growth next year|Cytek Biosciences, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year OSUR|Exagen Diagnostics - Earnings growth forecast for next year|MDXH (MDxHealth S.A.) - Projected earnings per share growth rate for next year|LUCD: Earnings growth forecast for next year|PRE - Consensus forecast of earnings per share growth for next year|IMDX (Insight Molecular Diagnostics, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Trinity Biotech Corp|Earnings growth forecast for next year PRPH|Ainos Inc (AIMD) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Co-Diagnostics Corp CODX|HSCS: Projected earnings per share growth rate for next year|BMRA - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year onconetix.gcs-web.com|Virax Biolabs (VRAX) - Net earnings per share growth forecast for next year|BJDX - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year AWH|AXDX (Accelerate Diagnostics Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year CNTG|Consensus forecast of earnings per share growth for next year enzo.com|Earnings growth forecast for next year FRES (Fresh2 Group)|GENE - Expected earnings per share growth for next year|ME - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Psychemedics Inc PMD
